The ubiquitin-editing enzyme A20 has a pivotal role in restricting autoimmune and inflammatory responses. New studies suggest that A20 prevents inflammatory diseases using a non-catalytic mechanism involving ubiquitin binding.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Targeting ubiquitin signaling for cancer immunotherapy
Signal Transduction and Targeted Therapy Open Access 13 January 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Martens, A. & van Loo, G. Cold Spring Harb. Perspect. Biol. 12, a036418 (2020).
Harhaj, E. W. & Dixit, V. M. Immunol. Rev. 246, 107–124 (2012).
Lu, T. T. et al. Immunity 38, 896–905 (2013).
De, A., Dainichi, T., Rathinam, C. V. & Ghosh, S. EMBO Rep. 15, 775–783 (2014).
Lee, E. G. et al. Science 289, 2350–2354 (2000).
Martens, A. et al. Nat. Immunol. https://doi.org/10.1038/s41590-020-0621-9 (2020).
Razani, B. et al. Nat. Immunol. https://doi.org/10.1038/s41590-020-0634-4 (2020).
Shaw, M. H., Kamada, N., Kim, Y.-G. & Nuñez, G. J. Exp. Med. 209, 251–258 (2012).
Skaug, B. et al. Mol. Cell 44, 559–571 (2011).
Sasaki, K. & Iwai, K. Immunol. Rev. 266, 175–189 (2015).
Polykratis, A. et al. Nat. Cell Biol. 21, 731–742 (2019).
Draber, P. et al. Cell Rep. 13, 2258–2272 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Sun, SC. A20 restricts inflammation via ubiquitin binding. Nat Immunol 21, 362–364 (2020). https://doi.org/10.1038/s41590-020-0632-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-020-0632-6
This article is cited by
-
Targeting ubiquitin signaling for cancer immunotherapy
Signal Transduction and Targeted Therapy (2021)